Proton Pump Inhibitor use in Hospitalized Patients: Is Overutilization Becoming a Problem?
Author(s) -
Cheryl Durand,
Kristine C. Willett,
Alicia R Desilets
Publication year - 2012
Publication title -
clinical medicine insights gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.373
H-Index - 11
ISSN - 1179-5522
DOI - 10.4137/cgast.s9588
Subject(s) - discontinuation , intensive care medicine , proton pump inhibitor , medicine , pneumonia , adverse effect , clostridium difficile , surgery , antibiotics , microbiology and biotechnology , biology
Proton pump inhibitors (PPIs) are among the most common classes of medications prescribed. Though they were previously thought of as safe, recent literature has shown risks associated with their use including increased risk for Clostridium difficile infection, pneumonia, and fractures. Due to these risks, it is important to determine if PPIs are being used appropriately. This review evaluates seven studies in hospitalized patients. Additionally, this review evaluates literature pertaining to recently discovered adverse reactions; all studies found PPIs are being overutilized. Findings highlight the importance of evaluating appropriate therapy with these agents and recommending discontinuation if a proper indication does not exist.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom